Signed LOI with Cartwheel - $21M over 5 years

ClearSight will manufacture and provide a private-label version of our innovative over-the-counter (OTC) pink eye treatment. Cartwheel will package and sell this product to major retail chains in the US under its brand. Cartwheel is set to launch its lice treatment in 2026 and will focus on introducing the ClearSight formulation in 2027.